FBIOX vs. FCNTX
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity Contrafund Fund (FCNTX).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. FCNTX is managed by Fidelity. It was launched on May 17, 1967.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBIOX or FCNTX.
Key characteristics
| FBIOX | FCNTX | |
|---|---|---|
| YTD Return | 22.06% | 32.72% |
| 1Y Return | 43.64% | 38.98% |
| 3Y Return (Ann) | -1.17% | 1.96% |
| 5Y Return (Ann) | 1.42% | 10.30% |
| 10Y Return (Ann) | 1.45% | 8.66% |
| Sharpe Ratio | 2.00 | 2.61 |
| Sortino Ratio | 2.76 | 3.49 |
| Omega Ratio | 1.33 | 1.49 |
| Calmar Ratio | 0.82 | 0.42 |
| Martin Ratio | 8.84 | 16.08 |
| Ulcer Index | 4.77% | 2.49% |
| Daily Std Dev | 21.04% | 15.36% |
| Max Drawdown | -71.96% | -99.34% |
| Current Drawdown | -26.26% | -93.08% |
Correlation
The correlation between FBIOX and FCNTX is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
FBIOX vs. FCNTX - Performance Comparison
In the year-to-date period, FBIOX achieves a 22.06% return, which is significantly lower than FCNTX's 32.72% return. Over the past 10 years, FBIOX has underperformed FCNTX with an annualized return of 1.45%, while FCNTX has yielded a comparatively higher 8.66% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. FCNTX - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than FCNTX's 0.39% expense ratio.
Risk-Adjusted Performance
FBIOX vs. FCNTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity Contrafund Fund (FCNTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBIOX vs. FCNTX - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 0.66%, more than FCNTX's 0.38% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 0.66% | 0.45% | 0.00% | 0.17% | 0.26% | 0.15% | 0.00% | 0.00% | 0.00% | 6.71% | 10.77% | 0.25% |
FCNTX Fidelity Contrafund Fund | 0.38% | 0.48% | 2.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.10% | 0.30% | 0.31% | 7.55% | 7.89% |
Drawdowns
FBIOX vs. FCNTX - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.96%, smaller than the maximum FCNTX drawdown of -99.34%. Use the drawdown chart below to compare losses from any high point for FBIOX and FCNTX. For additional features, visit the drawdowns tool.
Volatility
FBIOX vs. FCNTX - Volatility Comparison
Fidelity Select Biotechnology Portfolio (FBIOX) has a higher volatility of 4.25% compared to Fidelity Contrafund Fund (FCNTX) at 3.97%. This indicates that FBIOX's price experiences larger fluctuations and is considered to be riskier than FCNTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.